Viamet Pharmaceuticals Holdings, LLC
Overview
Viamet Pharmaceuticals, Inc., a private biotechnology company, specializes in the discovery, development, and commercialization of novel therapeutics for the treatment of diseases caused by fungal infections. The company's proprietary metalloenzyme platform allows for the identification of next-generation drugs that address the limitations of existing therapies.
Therapeutic areas
Infectious DiseasesAntifungal Therapies
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Viamet Pharmaceuticals Holdings, LLC in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.